to Investigate Impact of Diet and Physical Activity Based Nurse Led Interventions on Maternal Outcomes and Neonatal Outcomes in Women With Gestational Diabetes Mellitus (GDM)
Impact of Diet and Physical Activity Based Nurse Led Interventions on Maternal Outcome and Neonatal Outcomes in Women With Gestational Diabetes Mellitus (GDM): A Randomized Controlled Trial
1 other identifier
interventional
66
1 country
1
Brief Summary
Gestational Diabetes Mellitus (GDM) is a growing maternal health concern associated with adverse neonatal outcomes such as macrosomia and shoulder dystocia, often aggravated by poor dietary habits and physical inactivity during pregnancy. This randomized controlled study aims to evaluate the effectiveness of structured nursing interventions focusing on diet and physical activity in improving maternal glycemic control and reducing neonatal complications. A total of 66 pregnant women diagnosed with GDM will be selected through purposive sampling and randomly allocated into intervention and control groups using the lottery method. The intervention group will receive individualized dietary counselling, pregnancy-appropriate physical activity guidance, and regular nursing follow-up, while the control group will continue with routine antenatal care. Maternal outcomes, including fasting blood glucose and HbA1c levels, will be measured at baseline and follow-up visits. Neonatal outcomes such as macrosomia, mode of delivery, and shoulder dystocia will be documented at birth. Data will be collected using structured tools and analysed using SPSS, with independent t-tests and chi-square tests applied. The study anticipates that structured nursing interventions will significantly improve glycaemic control and reduce adverse neonatal outcomes, supporting the integration of evidence-based nursing care into routine GDM management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
February 11, 2026
February 1, 2026
6 months
December 24, 2025
February 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Maternal glycemic control assessed by HbA1c (%)
Change in maternal glycemic control measured by glycated hemoglobin (HbA1c, %) using standardized laboratory blood assays from baseline (at enrollment) to 36-38 weeks of gestation.
Baseline (at enrollment: 24-28 weeks gestation) to 36-38 weeks gestation
Fasting plasma glucose (mg/dL)
Change in fasting plasma glucose levels (mg/dL) measured using a fasting venous blood sample at baseline and at 36-38 weeks of gestation.
Baseline (24-28 weeks gestation) to 36-38 weeks gestation
Secondary Outcomes (5)
Mode of delivery
Mode of delivery (vaginal or cesarean section) recorded from hospital obstetric records at the time of childbirth.
Neonatal birth weight (grams)
Neonatal birth weight (grams) measured within the first hour after birth using a calibrated neonatal weighing scale.
Neonatal Apgar score
Apgar score assessed at 1 and 5 minutes after delivery using the standard Apgar scoring system.
Neonatal complications
Incidence of neonatal complications, including shoulder dystocia and neonatal hypoglycemia, assessed through standard clinical examination and review of neonatal medical records within 48 hours after birth.
Secondary Outcome Measure 5
Description: Maternal weight change measured in kilograms (kg) from enrollment to delivery using routine antenatal weight records.
Study Arms (2)
Control Arm: Standard Care
NO INTERVENTIONParticipants in the control group will receive standard care.
Experimental group
EXPERIMENTALExperimental group will receive nurse led intervention including diet,arm chair exercise and walk.
Interventions
Participants in the intervention group will receive nursing intervention sessions by researcher focusing on: * Dietary modifications based on caloric needs and glycemic index education. * Safe physical activity such as walk for 150 minutes per week (30 minutes daily). * Physical exercise under supervision of nurse physical activity guidance. * To assess in the management of gestational diabetes mellitus participants will be instructed to perform simple arm raises exercise using light weights. Each session will be scheduled for 10-15 minutes and conducted three times per weeks to promote upper body strength. Studied suggest that resistant training for 20 -30 minutes a week can reduce insulin resistance. The exercise regimen will be structured to incorporate these recommendations. Participants in the active arm exercise received written step prescriptions, and set individualized targets (Diabetes Canada, 2025). * Follow-up on alternate week (15 days) and 5 counseling sessio
Eligibility Criteria
You may qualify if:
- Pregnant women aged 18-40 years
- Diagnosed with GDM in the indexed pregnancy
- Singleton pregnancy. Pregnant women with gravida 02.
You may not qualify if:
- Pre-existing diabetes mellitus (Type 1 or Type 2)
- Multiple pregnancies (twins, triplets, etc.)
- Women with history of Pregnancy induced hypertension. (PIH)
- History of chronic medical conditions (renal disease, cardiac disorders, epilepsy)
- Psychiatric illness or cognitive impairment that may affect participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Of Health Sciences,Lahore.
Lahore, Punjab Province, 54000, Pakistan
Related Publications (1)
Brown J, Ceysens G, Boulvain M. Exercise for pregnant women with pre-existing diabetes for improving maternal and fetal outcomes. Cochrane Database Syst Rev. 2017 Dec 21;12(12):CD012696. doi: 10.1002/14651858.CD012696.pub2.
PMID: 29264871BACKGROUND
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dr. Lamia Yusuf, FCPS
Saglik Bilimleri Universitesi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSN Student
Study Record Dates
First Submitted
December 24, 2025
First Posted
February 3, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
February 11, 2026
Record last verified: 2026-02